DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carimune NF (Immune Globulin Intravenous) - Nuchal Rigidity - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Nuchal Rigidity (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carimune NF (Immune Globulin Intravenous) where reactions include nuchal rigidity. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Carimune NF side effects in female

Reported by a physician from United States on 2012-02-07

Patient: female

Reactions: Migraine, Nuchal Rigidity, Pain, Condition Aggravated, Rash, Pyrexia, Hyperhidrosis, Flushing, Meningitis Aseptic

Drug(s) suspected as cause:
Carimune NF
    Dosage: see image
    Indication: Myasthenia Gravis
    Start date: 2009-10-13

Carimune NF
    Dosage: see image
    Indication: Autonomic Neuropathy
    Start date: 2009-10-13

Carimune NF
    Dosage: see image
    Indication: Immunodeficiency
    Start date: 2009-10-13

Carimune NF
    Dosage: see image
    Indication: Myasthenia Gravis
    Start date: 2011-03-01

Carimune NF
    Dosage: see image
    Indication: Autonomic Neuropathy
    Start date: 2011-03-01

Carimune NF
    Dosage: see image
    Indication: Immunodeficiency
    Start date: 2011-03-01



Possible Carimune NF side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-23

Patient: female

Reactions: Migraine, Nuchal Rigidity, Condition Aggravated, Rash, Pyrexia, Blood Immunoglobulin G Decreased, Hyperhidrosis, Flushing, Neck Pain, Meningitis Aseptic

Drug(s) suspected as cause:
Carimune NF
    Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
    Indication: Myasthenia Gravis
    Start date: 2011-03-01

Carimune NF
    Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
    Indication: Autonomic Neuropathy
    Start date: 2011-03-01

Carimune NF
    Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
    Indication: Immunodeficiency
    Start date: 2011-03-01

Carimune NF
    Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
    Indication: Myasthenia Gravis
    Start date: 2009-10-13

Carimune NF
    Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
    Indication: Autonomic Neuropathy
    Start date: 2009-10-13

Carimune NF
    Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
    Indication: Immunodeficiency
    Start date: 2009-10-13

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017